What will the biio stock price be in the future?
Mar 30, 2022 · The company was formerly known as MJP International Ltd. and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland. As of October 7, 2020, Bionovate Technologies Corp. operates as a subsidiary of Human Data AG. View less.
Should I trade bionovate Technologies Corp (biio) stock?
BIIO | Complete Bionovate Technologies Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Which way will biio go?
Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionovate Technologies share forecasts, stock quote and buy / sell signals below. According to present data Bionovate Technologies's BIIO shares and potentially its market environment have been in bearish cycle last 12 months (if exists).
What does biiou stand for?
Apr 11, 2022 · Data sources: Yahoo! Finance, company websites. Market caps as of Jan. 18, 2022. 1. Axsome Therapeutics. Axsome's lead drug candidate, which it …
Is BIIO good stock to buy?
Our Ai stock analyst implies that there will be a negative trend in the future and the BIIO shares are not a good investment for making money. Since this share has a negative outlook we recommend looking for other projects instead to build a portfolio.
What does BIIO company do?
BIO is the world's largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries.
What does Bionovate do?
Bionovate Technologies Corp. manufactures lighting fixtures. The Company produces and markets light-emitting diode lighting products. Bionovate Technologies serves customers in North America and China.Jun 5, 2019
Is biotechnology innovation organization a non profit?
BIOTECHNOLOGY INNOVATION ORGANIZATION is a 501(c)(6) organization, with an IRS ruling year of 1982, and donations may or may not be tax-deductible. Is this your nonprofit? Access the Nonprofit Portal to submit data and download your rating toolkit.
How many members does BIO have?
1,200 membersBIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide.
"Should I invest in Bionovate Technologies stock?" "Should I trade "BIIO" stock today?"
According to our live Forecast System, Bionovate Technologies Corp stock is an awesome long-term (1-year)...
What is the Bionovate Technologies stock price / share price today?
The Bionovate Technologies stock price is 0.080 USD today.
Will Bionovate Technologies stock price grow / rise / go up?
Yes. The BIIO stock price can go up from 0.080 USD to 0.726 USD in...
Is it profitable to invest in Bionovate Technologies stock?
Yes. The long-term earning potential is + 806.88 % in one year.
Will BIIO stock price fall / drop?
No. See above .
What will Bionovate Technologies stock price be worth in five years (2027)?
The BIIO ("BIIO" ) future stock price will be 0.424 USD .
Will BIIO stock price crash?
According to our analysis, this will not happen.
Will Bionovate Technologies stock price hit 1 USD price in a year?
Not within a year. See above .
Will Bionovate Technologies stock price hit 5 USD price in a year?
Not within a year. See above .
Bionovate applies to list on NASDAQ
CHAM, Switzerland, May 03, 2021 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp., traded on OTC Markets (OTCPK:BIIO), announced that it has submitted a formal application to list its common shares (“Shares”) on the NASDAQ Stock Exchange (“NASDAQ”).
Bionovate announces to reduce shares
CHAM, Switzerland, April 30, 2021 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp., traded on OTC Markets (OTCPK:BIIO), announces the cancellation and return to treasury of 25,000,000 common shares of the company’s stock.
Bionovate Supports Startups in the Digital Health Markets
CHAM, Switzerland, March 04, 2021 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp (OTCMKT: BIIO) (“Bionovate”), is currently in the process of compiling a shortlist for potential investments in start-ups in the digital healthcare markets, as announced.
Bionovate Announces Return of Shares to Treasury
CHAM, Switzerland, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp., traded on the Nasdaq OTC (OTCPK:BIIO), announces the cancellation and return to treasury of 13,820,000 common shares of the company’s stock.
Bionovate seeks to invest in Health and Life Care Startups
CHAM, Switzerland, Dec. 03, 2020 (GLOBE NEWSWIRE) -- Bionovate Technologies Corp., traded on the Nasdaq OTC (OTCPK:BIIO), plans to strategically invest in startups in Europe in the health and life care sector and focus its investments strategy towards on-demand healthcare services.
Bionovate realigns its strategy: from Quantify Yourself to Know Yourself
CHAM, Switzerland, Nov. 27, 2020 (GLOBE NEWSWIRE) -- The medical device company Bionovate Technologies Corp adopts a strategic reorientation under new management. Aleksandar Vucak will realign the company as CEO after taking over the majority of the shares of the company, traded on the Nasdaq OTC (OTCPK:BIIO). Bionovate Technologies Corp.
Bionovate Technologies picks up semanticom for international PR
CHAM, Switzerland and BERLIN, Oct. 17, 2020 (GLOBE NEWSWIRE) -- The Berlin public relations agency wins the business with international PR and strategic corporate communications of the medical device company Bionovate Technologies Corp. The shares of the company are traded on the Nasdaq OTC (OTCPK:BIIO).Bionovate Technologies Corp.
Where is Bionovate located?
and changed its name to Bionovate Technologies Corp. in December 2017. Bionovate Technologies Corp. was founded in 2010 and is based in Cham, Switzerland.
What is equity summary score?
The Equity Summary Score is an accuracy-weighted sentiment derived from the ratings of independent research providers on Fidelity.com. It uses the past relative accuracy of the providers in determining the emphasis placed on any individual opinion. Learn More....
What is Bionovate technology?
Bionovate Technologies Corp., a medical device company, focuses on developing automated treatment for age spots. It intends to develop and provide automated computerized system that treats age spots anywhere on the body. The company targets to sell its systems to physicians and spas worldwide.
BIIO Target Price
BIIO price target in 14 days: 1.263 USD* upside and 0.836 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Bionovate Technologies Corp ( BIIO ) Stock Market info
Recommendations: Buy or sell Bionovate Technologies stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Bionovate Technologies share forecasts, stock quote and buy / sell signals below.
Bionovate Technologies Corp ( BIIO ) Stock Price Prediction, Stock Forecast for next months and years
Below you will find the price predictions for 2021, 2022, 2023, 2024, 2025, 2026.
What is Axsome 05?
Axsome Therapeutics. Axsome's lead candidate drug, which it calls AXS-05, targets depression and Alzheimer’s disease-related agitation. In early 2021, the company formally filed for U.S. regulatory approval for the drug to treat depression. It’s also evaluating AXS-05 in a phase 2 study for smoking cessation.
Who makes Eylea?
Regeneron Pharmaceuticals. The biggest moneymaker for Regeneron Pharmaceuticals is Eylea, an eye disease drug it makes in collaboration with Bayer (OTC:BAYRY). All net sales from Eylea in the U.S. are awarded to Regeneron, and the company splits with Bayer the revenue earned from markets outside of the U.S.
How are drug candidates tested?
Clinical testing: The drug candidate is tested on humans. Clinical testing generally occurs in three phases: 1 Phase 1: Small studies are conducted to find a safe dose for the drug candidate and determine how the drug affects humans. 2 Phase 2: Larger studies involving around 100 or more patients are conducted with a focus on safety and short-term side effects and to determine the optimal dose for the drug. 3 Phase 3: Even larger studies, with hundreds or even thousands of patients, are conducted to demonstrate how effectively and safely the experimental drug treats the target disease.
What is biotech company?
What exactly is a biotech? It’s a company that uses living organisms (for example, bacteria or enzymes) to make drugs. This use of living organisms differentiates biotechs from pharmaceutical companies, which use chemicals to develop drugs.
What is phase 1 of a drug?
Phase 1, which involves small studies designed to find a safe dose for the drug candidate and determine how it affects humans. Phase 2, which involves studies that can include around 100 or more patients and focus on safety, short-term side effects, and determining the optimal dose for the drug.
What is the importance of biotech?
Another important thing to watch with biotechs is their financial positions. Most biotechs don’t achieve profitability until they successfully launch one or more drugs in the market. They require significant amounts of cash to fund operations and advance their pipeline candidates.
Is Cabometyx approved for liver cancer?
The drug is approved for treating renal cell carcinoma (RCC) and hepatocellular carcinoma (HCC), the most common types of kidney cancer and liver cancer, respectively. This biotech company could deliver solid growth in the future by expanding the use of Cabometyx as part of combination therapies. Exelixis and Bristol Myers Squibb (NYSE:BMY) ...
Component Grades
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
Bionovate Technologies Corp. (BIIO) Company Bio
Bionovate Technologies Corp. manufactures lighting fixtures. The Company produces and markets light-emitting diode lighting products. Bionovate Technologies serves customers in North America and China.
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
How long does it take for a stock to spike?
This phase often takes two to three years. After a company successfully passes a phase, its stock can spike in price. The good news can draw trader and investor interest in the company’s prospects for future profits. Of course, these spikes in price can and do often fail.
Where is CELG based?
CELG is based out of New Jersey and specializes in developing medicines for cancer and inflammatory disorders. It’s a big name in the sector with a current market cap north of $60 billion.
What agency does a company need to pass drug testing?
In the United States, if a company wants to develop and sell a drug to the public, they need to pass stringent testing by the government’s Food and Drug Administration Agency (FDA).
What is an OBLN?
OBLN is a tiny firm that focuses on developing medical devices to assist in weight loss for overweight and obese people. When I say tiny, I mean it — they currently have a market cap of just over $15 million.
Is biotech a volatile sector?
Biotech stocks are consistently one of the most exciting sectors with many volatile stocks. If the sector clicks with your trading style, there can be plenty of trading opportunities. But remember, as always, to do your homework.
